Metastatic Solid Tumor Clinical Trials in Grand Rapids, Michigan

4 studies are recruiting for metastatic solid tumor in Grand Rapids, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

    This interventional study will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ART6043 as monotherapy or in combination with olaparib.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    South Texas Accelerated Research Therapeutics (START) - Midwest, Grand Rapids, Michigan
    Locations
    18 in total
    Run by
    Artios Pharma Ltd

    See if you can join NCT05898399 on ClinicalTrials.gov

  2. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including urothelial cancer. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids, Michigan
    Locations
    39 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06465069 on ClinicalTrials.gov

  3. A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

    The purpose of this study is to determine the appropriate dosage, safety and effectiveness of a new drug, IPN01203, in adults with advanced solid tumours. Advanced solid tumours are cancers that can occur in various organs or tissues and have spread from their original site to nearby tissues or oth…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    South Texas Accelerated Research Therapeutics (START) - Midwest, Grand Rapids, Michigan
    Locations
    10 in total
    Run by
    Ipsen

    See if you can join NCT07213830 on ClinicalTrials.gov

  4. A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

    This study aims to find the right dosage and evaluate the safety and effectiveness of the drug IPN60300 in adults with advanced solid tumours, which are cancers that have spread to other parts of the body from their original location. All participants will receive the drug by injection. Study Phase…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    START Midwest, Grand Rapids, Michigan
    Locations
    12 in total
    Run by
    Ipsen

    See if you can join NCT07213817 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.